Conversion back to bevacizumab or ranibizumab for recurrent neovascular activity with aflibercept in age-related macular degeneration: a case series

by Slean, Geraldine R., Hemarat, Kornwipa, Khurana, Rahul N., Stewart, Jay M.
Published 2016